Gelstat

GSAC · OTC

Price unavailable right now.

Prev close $0.0003

About GSAC

GelStat Corp. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Miami, Florida. The Company’s products include Intelligent Control Automation System (ICAS), Encrypted Control Device (ECD), and Variable Base Encryption Compression (VBEC). ICAS integrates control, telemetry, video, and communications in a seamless interface designed to control complex processes with limited human resources. ICAS offers customized automation solutions that align with the specific requirements of industrial processes without disrupting their current operations. ECD is a multi-platform input/output solution designed to maintain secure control management. VBEC is an efficient compression protocol to enable transmission of AES-256 encryption blocks fragmented into smaller length packets compatible with existing 2.4 GHz airwaves. The firm's subsidiary, GSAC Engineering Corporation, is engaged in the development of technologies for clean energy and industrial security.

Employees
0
Headquarters
Miami, Florida
Listed
Apr 23, 1993
Sector
Health Care
Industry
Pharmaceuticals

GSAC key statistics

This section is temporarily unavailable. Refresh to try again.

GSAC news

  • Press releaseGlobe Newswire

    GSAC Engineering Secures Multi-Year Recurring Revenue Contract

Similar companies

Companies in the same industry as Gelstat

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.